Exploiting the peptidome of atypical teratoid/rhabdoid tumors - characterization of novel tumor-associated antigens for immunotherapy in order to maintain long-term remissions
An integrated approach for epigenetic risk assessment and biomarker development for breast cancer in prospective cohorts / Identifying early epigenetic predictors of breast cancer risk and their etiology determinants
Evolution of resistant clones to novel target-directed drugs in colorectal tumors. - A genetic and epigenetic study of intratumoral heterogeneity dynamics
We use necessary technologies to operate this website. With your permission, we also use analytics technologies
from Google Analytics and Metricool to understand how the site is used. You can accept, reject or configure
non-essential technologies at any time.
Cookie settings
Necessary
Required for core website functions and to remember your privacy choice.
Always active
Google Analytics 4 and Metricool help us understand website usage and performance.
Reserved for optional marketing or campaign technologies, such as future Mailchimp tracking.